Abstract
Background: The article describes how a new robust HPTLC method was developed to separate and quantify aspirin, clopidogrel bisulphate and rosuvastatin calcium in a fixed dose combination present in a capsule dosage form using quality by the design approach.
Methods: A central composite experimental design has been framed and results were analysed by using a modern statistical technique called response surface methodology in order to study the effects of chromatographic chamber saturation time, volumes of ionic modifier and mobile phase ratio on Rf value and band shape. Results: The Rf value predicted for aspirin, clopidogrel bisulphate and rosuvastatin calcium was in between 0.3 and 0.84. After optimization, the chromatographic conditions were 20 min saturation time and 7:3:0.2 v/v/v as the ratio of ethyl acetate, chloroform and pH modifier (Glacial Acetic acid) as a mobile phase. The LOD was found 45.2 ng band-1 15.9 ng band-1 and 6.8 ng band-1; and the LOQ was found 150.7 ng band-1 53.05 ng band-1 and 22.7 ng band-1 for AS, CL and RO respectively Conclusion: The optimized HPTLC method was validated according to (ICH) guideline Q2 (R1). The results prove that QbD concept effectively optimizes HPTLC methods with the minimum number of experiments. Developed HPTLC method was successfully applied for commercial samples of aspirin, clopidogrel bisulphate and rosuvastatin calcium in triple combination capsule dosage form.Keywords: HPTLC, QbD, central composite design, response surface methodology, anti-hyperlipemic drug, aspirin.
Graphical Abstract
Current Analytical Chemistry
Title:A Robust QBD Based High-Performance Thin-Layer Chromatographic Method for the Estimation of Aspirin, Clopidogrel Bisulphate and Rosuvastatin Calcium in a Pharmaceutical Formulation Using Experimental Design
Volume: 13 Issue: 5
Author(s): A.S.K. Sankar*, P. Shanmugasundaram and V. Ravichandiran
Affiliation:
- Research Scholar and Faculty at School of Pharmaceutical Sciences, Vels University (VISTAS), Chennai,India
Keywords: HPTLC, QbD, central composite design, response surface methodology, anti-hyperlipemic drug, aspirin.
Abstract: Background: The article describes how a new robust HPTLC method was developed to separate and quantify aspirin, clopidogrel bisulphate and rosuvastatin calcium in a fixed dose combination present in a capsule dosage form using quality by the design approach.
Methods: A central composite experimental design has been framed and results were analysed by using a modern statistical technique called response surface methodology in order to study the effects of chromatographic chamber saturation time, volumes of ionic modifier and mobile phase ratio on Rf value and band shape. Results: The Rf value predicted for aspirin, clopidogrel bisulphate and rosuvastatin calcium was in between 0.3 and 0.84. After optimization, the chromatographic conditions were 20 min saturation time and 7:3:0.2 v/v/v as the ratio of ethyl acetate, chloroform and pH modifier (Glacial Acetic acid) as a mobile phase. The LOD was found 45.2 ng band-1 15.9 ng band-1 and 6.8 ng band-1; and the LOQ was found 150.7 ng band-1 53.05 ng band-1 and 22.7 ng band-1 for AS, CL and RO respectively Conclusion: The optimized HPTLC method was validated according to (ICH) guideline Q2 (R1). The results prove that QbD concept effectively optimizes HPTLC methods with the minimum number of experiments. Developed HPTLC method was successfully applied for commercial samples of aspirin, clopidogrel bisulphate and rosuvastatin calcium in triple combination capsule dosage form.Export Options
About this article
Cite this article as:
Sankar A.S.K.*, Shanmugasundaram P. and Ravichandiran V., A Robust QBD Based High-Performance Thin-Layer Chromatographic Method for the Estimation of Aspirin, Clopidogrel Bisulphate and Rosuvastatin Calcium in a Pharmaceutical Formulation Using Experimental Design, Current Analytical Chemistry 2017; 13 (5) . https://dx.doi.org/10.2174/1573411013666170127163707
DOI https://dx.doi.org/10.2174/1573411013666170127163707 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in Antiarrhythmic Drug Treatment of Atrial Fibrillation
Recent Patents on Cardiovascular Drug Discovery PREFACE
Cardiovascular & Hematological Agents in Medicinal Chemistry HSP70 Family in the Renal Inflammatory Response
Inflammation & Allergy - Drug Targets (Discontinued) Preclinical Evaluation of Coronary Stents: Focus on Safety Issues
Current Vascular Pharmacology Managing Erectile Dysfunction in Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity
Current Neuropharmacology Structure-activity Relationship of Chemical Penetration Enhan-cers in Transdermal Drug Delivery
Current Medicinal Chemistry Neonatal Systemic Thrombosis: An Updated Overview
Current Vascular Pharmacology Rational Autologous Cell Sources For Therapy of Heart Failure - Vehicles and Targets For Gene and RNA Therapies
Current Gene Therapy New Anti-Malarial Drugs: Who Cares?
Current Topics in Medicinal Chemistry Cellular Mechanisms of Bypass Vein Graft Arterialization and Approaches to Attenuate Graft Remodeling
Vascular Disease Prevention (Discontinued) The Crosstalk between Tissue Engineering and Pharmaceutical Biotechnology: Recent Advances and Future Directions
Current Pharmaceutical Biotechnology Novel Targets in Multiple Sclerosis: To Oxidative Stress and Beyond
Current Topics in Medicinal Chemistry The Utilization of Gene Targeting Models During in Preclinical Study of Drug Discovery Process - Example of Phenotypic and Functional Analysis of Cacna1 βGene Product
Current Pharmaceutical Biotechnology Anti-Inflammatory, Gastrointestinal and Hepatoprotective Effects of Ocimum sanctum Linn: An Ancient Remedy with New Application
Inflammation & Allergy - Drug Targets (Discontinued) The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise
Current Molecular Medicine Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application
Current Drug Targets Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
Current Medicinal Chemistry Aquaporins and Glia
Current Neuropharmacology